Outcomes4Me Secures $21M to Revolutionize Cancer Care with AI Advancements
Deal News | May 29, 2025 | PR Newswire Cision Outcomes4Me Inc.
Outcomes4Me Inc., a company based in Boston, announced a $21 million funding round intended to accelerate its AI-driven platform aimed at transforming cancer care. The funding was led by Salica Investments with participation from existing investors such as Labcorp Venture Fund, Forecast Labs, and several others. This capital infusion brings Outcomes4Me's total funding to $38 million. The company aims to use this investment to enhance their platform, expand globally, and drive substantial revenue growth. Outcomes4Me specializes in personalizing cancer patient experiences through an AI-enabled platform that integrates clinical guidelines, genomic insights, and trial matching, among other features. Since its launch in 2022, the company has witnessed significant revenue growth and boasts clients that include seven of the top ten global cancer pharmaceutical companies. Outcomes4Me is set to accelerate market penetration, expand its AI capabilities, and strengthen collaborations globally as it positions itself as a leader in the digital health cancer care market.
Sectors
- Healthcare Technology
- Artificial Intelligence
- Biotechnology
Geography
- United States – Outcomes4Me is based in Boston, Massachusetts, highlighting the company's American base.
- United Kingdom – Salica Investments, one of the new investors, is based in London, indicating UK relevance.
Industry
- Healthcare Technology – The article focuses on Outcomes4Me, which offers an AI-driven platform for cancer care, thus falling under the Healthcare Technology industry.
- Artificial Intelligence – Outcomes4Me's innovative use of AI to deliver personalized treatment options for cancer patients makes this industry relevant.
- Biotechnology – The integration of genomic insights and clinical trial matching in cancer care solutions makes this sector pertinent.
Financials
- $21M – The amount raised in the latest funding round by Outcomes4Me.
- $38M – The total capital raised to date by Outcomes4Me.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Outcomes4Me Inc. | Target company | Company | A Boston-based developer of an AI-driven cancer care platform. |
| Salica Investments | New investor | Company | A London-based investment firm participating in the latest funding round. |
| Labcorp Venture Fund | Existing investor | Company | An investor participating again in this funding round. |
| Maya R. Said | Founder and CEO | Person | The founder and CEO of Outcomes4Me. |
| Amy Summy | Executive Vice President, CMO & Consumer Lead | Person | Labcorp's executive supporting Outcomes4Me's platform. |